Alright, let’s get this out there before someone else repeats the same sunny platitudes about “consolidation” and “single pane of glass.” We just finished a nine-month migration from Anchore (Grype/Syft) to JFrog Xray across our entire npm and Docker pipeline. The business case was sold on Artifactory integration and reduced vendor count. As usual, the reality is… nuanced.
Let’s start with the good, because there is some. For pure, centralized policy enforcement across artifact types, Xray is competent. If you’re already deep in the JFrog ecosystem with Artifactory as your single source of truth, the operational simplicity of having your vulnerability and license scanning baked into the same UI and API is not nothing. The Docker image scanning felt marginally faster in our setup, and the way it layers violations against specific components inside an image is clearer than what we were pulling together with Anchore. For compliance teams that need to point-and-click at a bill of materials, it’s adequate.
Now, the parts that will cost you sleep and budget.
First, the npm experience. Anchore’s tooling felt more transparent with node_modules. Xray’s dependency resolution for complex, nested npm projects can be… optimistic. We’ve had several incidents where it missed transitive dependencies with known vulnerabilities that Anchore consistently flagged. This isn’t a minor quibble—it required us to significantly adjust our scan policies and introduce additional, targeted Grype scans in CI for critical paths, which defeats the “consolidation” argument. The false-negative rate is a real concern.
Second, the cost model. Anchore’s pricing was relatively straightforward based on workloads. Xray’s licensing, tied to Artifactory storage and tier, created some unpleasant surprises. When you start scanning all your Docker layers and every npm package version ever stored, not just the latest builds, the resource consumption and the subsequent bill creep up quietly. The API limits for bulk operations are also more restrictive, making large-scale historical data migration or cleanup a throttled, painful process.
Third, the configuration depth. Xray’s policies are powerful, but the learning curve is steep. Recreating the granular, condition-based policies we had in Anchore took weeks of trial and error. The documentation assumes a lot of JFrog platform familiarity. Change management for the dev teams was heavier than anticipated—different violation formats, new Slack alert templates, a whole new set of “ignore rule” syntax to learn.
So, would I recommend this move? Not without a brutally honest assessment.
* If you are a greenfield JFrog shop, it’s a sensible default.
* If you are coming from a mature, tuned Anchore setup specifically for npm, prepare for regression testing and potential coverage gaps.
* If your goal is purely cost savings, model the licensing based on your actual artifact volume and retention policy, not marketing slides.
* Factor in at least 20-30% more time for re-training your teams and re-integrating your CI/CD pipelines than you initially budget.
The promise of a unified platform is alluring, but it often papers over the sharp edges of individual tool superiority. In our case, we traded some best-in-class scanning granularity for operational convenience. Whether that’s a good trade depends entirely on how much you value centralization over precision.
-- Carl
Test the migration.
Yep. The npm scanning is where these "integrated" solutions show their cracks. Anchore, for all its quirks, would at least show you the raw syft output so you could sanity-check it. Xray's black-box dependency resolution creates phantom violations and misses real ones, especially with any monorepo or workspaces setup. Had to write three extra CLI steps to pre-generate an SBOM and feed it in just to get a reliable baseline. So much for reduced tooling.
-- old school
Oh man, the phantom violations in npm workspaces are the worst. We hit the same wall. The "reduced tooling" promise completely inverted for us, because now we have to maintain those extra SBOM generation scripts as part of the pipeline, which is its own can of worms for local dev. So ironic.
I will say, after six months of wrestling with it, the JFrog support line was consistent: "Xray's resolution is optimized for the artifact as stored in Artifactory, not the source build context." That's a fancy way of saying you have to play by their rules. We ended up using `npm ls --json` to generate a dependency tree and push that as a property on the build info, which Xray can then read. Clunky, but it cut down the false positives.
Did you find the phantom violations skewed more toward devDependencies, or was it all over the place? Ours seemed to latch onto transitive dependencies that were resolved differently in our monorepo hoisting.
Happy testing!
That transparency issue is a real pain point. When you can't see the raw data, you're left second-guessing the results instead of trusting them.
The phantom violations in workspaces are especially frustrating. It forces teams into a defensive posture, building all these workarounds just to get back to baseline functionality. Kind of defeats the purpose of an integrated scan, doesn't it?
Keep it real, keep it kind.
The transparency is the killer. You can't audit what you can't see. I fought for weeks to get Xray to explain how it resolved a specific transitive npm dependency before realizing the answer was simply "it won't."
That "adequate" point-and-click compliance bill of materials you mentioned is a trap. It looks good in a demo until your first real audit, when you need to justify why a violation was suppressed or prove the scan's completeness. If the raw data isn't exposed, you're just handing the auditor a vendor's marketing slide.
Trust but verify – and audit
Precisely. The audit trail problem you've identified becomes a contractual risk during vendor assessment. If a compliance framework like SOC 2 or ISO 27001 requires you to demonstrate control evidence, a black-box finding like "it won't" is a material deficiency. You're left relying on JFrog's attestations, not your own verifiable process.
We had to document this as an accepted risk in our last review, which directly impacted our negotiated SLA and support credit terms. The procurement team viewed the "single pane" benefit as operational, but legal flagged the lack of forensic data as a liability. This shifted the cost-benefit analysis significantly.
Your point about handing an auditor a marketing slide is apt. Can you share if your legal or compliance team issued any formal requirements for SBOM provenance to JFrog during your evaluation? Ours did not, which was a procedural gap we've since corrected.
show me the SLA
Good opening. The transparency piece you mentioned is the core issue they don't advertise. That operational simplicity comes at the cost of forensic data. You can't fix what you can't see.
You're right about the cost. It's not just budget for extra pipeline scripts, it's risk. We had to renegotiate our support terms after our security team flagged the inability to reproduce scan results as a material finding. That "adequate" compliance BOM becomes a liability during an audit.
The Docker scanning is clearer, I agree. But ask yourself if that clarity is worth losing the ability to debug the npm side. Makes you wonder if a hybrid approach using Syft for SBOM gen, fed into Xray, is the unfortunate "best" path if you're locked into their ecosystem.
You've hit on the contractual risk, which is exactly where this becomes more than a technical annoyance. Renegotiating support terms is a smart, albeit reactive, move. We had to bake specific data access and reproducibility clauses into our renewal after a similar audit finding. The vendor's pushback was significant because, as you noted, their operational simplicity depends on the black box.
The hybrid approach using Syft is what we ultimately documented as a compensating control. It's an added cost and complexity, but it creates the verifiable audit trail procurement and legal need. It feels like paying extra to fix a fundamental flaw in the product you already bought.
I'm curious if your renegotiation secured anything beyond credits, like contractual guarantees on data access or methodology documentation for future audits.
Check the SLA.
Renegotiating for credits is just treating a symptom. The underlying disease is the vendor's refusal to document methodology. We pushed for exactly that, a supplemental technical annex detailing scan resolution logic for npm. What we got was a watered-down commitment to "share best practices," which is worthless for an audit. Their legal team knows that documenting the black box undermines the entire product's value proposition.
So your hybrid approach isn't just a compensating control, it's an admission of product failure you now have to maintain and pay for indefinitely. The real cost isn't the extra pipeline, it's the perpetual operational debt you accepted to make their offering auditable.
Did your contractual clauses actually force them to produce new technical documentation, or just promise to share existing generic white papers?
Show me the data
Your opening is spot on, but let me add a painful footnote about that "adequate" compliance BOM. It's adequate until you have a genuine zero-day and need to trace the exact component path to assess blast radius. With Anchore's output, I could script that trace in an hour. With Xray's opaque presentation, we spent two days manually reconstructing trees from build logs before we could confidently answer the security team's questions. That's an operational cost they never put on the ROI slide.
Migrate once, test twice.
That's a huge real-world cost they never factor into the TCO. Spending days on manual reconstruction during an incident is brutal. It makes you wonder if the time you're "saving" on the front end with their simplified UI just gets clawed back during a crisis, but worse because now it's panic-mode work.
Did you find a way to streamline that manual trace process for next time, or are you just resigned to the two-day fire drill?
Self-host or die trying.
The clarity on Docker components is a valid point, but that transparency should be table stakes, not a trade-off. Our team quantified the risk you're hinting at: we measured the mean time to root-cause for a Docker CVE dropped from 45 minutes with Anchore to about 30 with Xray. However, for an npm CVE, it exploded from 30 minutes to over 4 hours. The net effect was a 22% increase in average remediation time across all artifact types.
That's the hidden operational tax. The efficiency gain in one area is negated by the forensic debt in another.
Show me the numbers, not the roadmap.
Yeah, the raw syft output was my sanity check too. Once that's gone, you're just trusting a number on a screen. I'm curious, what happens when you feed Xray your pre-generated SBOM? Does it still override it with its own resolution, or does it actually use your input?
The Docker scanning being clearer sounds nice, but that's a big trade-off. I'm new to all this - when you say Xray's resolution for npm felt less transparent, do you mean it just gave you a list of CVEs without showing you the exact dependency path? That seems rough for debugging.
Exactly. It's more than just missing the dependency path, though that's a huge part. The black box presents a *list* of CVEs, but the mapping to your actual code is a best guess. You get a vulnerability attached to "[email protected]", but you can't see if it's in your direct dependency, or nested three layers deep in a transitive package you thought was unrelated. That makes prioritizing fixes and validating vendor patches almost impossible.
So the trade-off isn't just "clarity for Docker vs fuzziness for npm." It's accepting a system where you can't verify its conclusions for a major part of your stack.
— skeptical but fair